Editöre Mektup

Uygun maliyetli ve kolay ulaşılabilir bir belirteç olarak platelet/lenfosit oranı

Cilt: 41 Sayı: 3 30 Eylül 2016
Murat Afyon
PDF İndir
EN TR

Platelet-to-lymphocyte ratio as a cost-effective and easily measurable marker

Öz

Kaynakça

  1. Alan S, Tuna S, Türkoğlu EB. The relation of neutrophil-to-lymphocyte lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet’s syndrome. Kaohsiung J Med Sci. 2015;31:626-31. platelet-to
  2. Zencir C, Akpek M, Senol S, Selvi M, Onay S, Cetin M et al. Association between hematologic parameters and in-hospital mortality in patients with infective endocarditis. Kaohsiung J Med Sci 2015;31:632-8.
  3. Kurtipek E, Bekci TT, Kesli R, Sami SS, Terzi Y. The role of neutrophil-lymphocyte ratio and platelet- lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease. J Pak Med Assoc. 2015;65:1283-7.
  4. Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H et al. Neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2015:1-16. [Epub ahead of print].
  5. Kim DS, Shin D, Lee MS, Kim HJ, Kim DY, Kim SM et al. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol. 2016;43:305-10.
  6. Koseoglu S, Ozcan KM, Ikinciogullari A, Cetin MA, Yildirim E, Dere H. Relationship between neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and obstructive sleep apnea syndrome. Adv Clin Exp Med. 2015;24:623-7.
  7. Ozgonul C, Sertoglu E, Mumcuoğlu T, Ozge G, Gokce G. Prediction of pseudoexfoliation syndrome and pseudoexfoliation glaucoma by using neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Ocul 10.3109/09273948.2015.1063671. 2015;doi:
  8. Tagawa T, Anraku M, Morodomi Y, Takenaka T, Okamoto T, Takenoyama M et al. Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy. J Thorac Dis. 2015;7:1898-906.
  9. Nakamura K, Nishida T, Haruma T, Haraga J, Omichi C, Ogawa C et al. Pretreatment platelet- lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation 2015;3:1001-6. Mol Clin Oncol.
  10. Goh BK, Chok AY, Allen JC Jr, Quek R, Teo MC, Chow PK et al. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic gastrointestinal 2016;159:1146-56.. surgically tumors. Surgery. stromal

Kaynak Göster

APA
Afyon, M. (2016). Platelet-to-lymphocyte ratio as a cost-effective and easily measurable marker. Cukurova Medical Journal, 41(3), 610-611. https://doi.org/10.17826/cukmedj.237554
AMA
1.Afyon M. Platelet-to-lymphocyte ratio as a cost-effective and easily measurable marker. Cukurova Med J. 2016;41(3):610-611. doi:10.17826/cukmedj.237554
Chicago
Afyon, Murat. 2016. “Platelet-to-lymphocyte ratio as a cost-effective and easily measurable marker”. Cukurova Medical Journal 41 (3): 610-11. https://doi.org/10.17826/cukmedj.237554.
EndNote
Afyon M (01 Eylül 2016) Platelet-to-lymphocyte ratio as a cost-effective and easily measurable marker. Cukurova Medical Journal 41 3 610–611.
IEEE
[1]M. Afyon, “Platelet-to-lymphocyte ratio as a cost-effective and easily measurable marker”, Cukurova Med J, c. 41, sy 3, ss. 610–611, Eyl. 2016, doi: 10.17826/cukmedj.237554.
ISNAD
Afyon, Murat. “Platelet-to-lymphocyte ratio as a cost-effective and easily measurable marker”. Cukurova Medical Journal 41/3 (01 Eylül 2016): 610-611. https://doi.org/10.17826/cukmedj.237554.
JAMA
1.Afyon M. Platelet-to-lymphocyte ratio as a cost-effective and easily measurable marker. Cukurova Med J. 2016;41:610–611.
MLA
Afyon, Murat. “Platelet-to-lymphocyte ratio as a cost-effective and easily measurable marker”. Cukurova Medical Journal, c. 41, sy 3, Eylül 2016, ss. 610-1, doi:10.17826/cukmedj.237554.
Vancouver
1.Murat Afyon. Platelet-to-lymphocyte ratio as a cost-effective and easily measurable marker. Cukurova Med J. 01 Eylül 2016;41(3):610-1. doi:10.17826/cukmedj.237554